SEC Form 4 · accession 0001437749-17-015334
ZEVRA THERAPEUTICS, INC. · ZVRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gordon K Johnson
Officer — Chief Business Officer
Period of report
Aug 24, 2017
Accepted (ET)
Aug 25, 2017 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434647
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 24, 2017 | P | 1,000 | $2.55 | A | 3,000 | D | |
| Common Stock | Aug 24, 2017 | P | 2,000 | $2.6137 | A | 5,000 | D | |
| Common Stock | Aug 24, 2017 | P | 1,000 | $2.6264 | A | 6,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney.